Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participants on hemodialysis between the ages of 18 and 70 years, with serum potassium levels of at least 5.5 mmol/L~* Adequately dialyzed (Kt/V ≥ 1.2)~Exclusion Criteria:~* History of bowel obstruction, swallowing disorders, severe gastrointestinal disorders or major gastrointestinal surgery.~* Severe constipation or irregular bowel habits.~* Unable to consume or tolerate the study-specific diet.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- patiromer (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).